Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00364611
Status:
COMPLETED
Last Update Posted:
2012-08-23
First Post:
2006-08-14
Brief Title:
Pilot Study of Docetaxel Bevacizumab - Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer
Sponsor:
Sanofi
Organization:
Sanofi
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
Keywords: